These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21035313)

  • 41. Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study.
    Thompson A; Nelson B; Bechdolf A; Chanen AM; Domingues I; McDougall E; Yung AR
    Early Interv Psychiatry; 2012 Aug; 6(3):247-55. PubMed ID: 22672502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.
    Takahashi T; Wood SJ; Yung AR; Phillips LJ; Soulsby B; McGorry PD; Tanino R; Zhou SY; Suzuki M; Velakoulis D; Pantelis C
    Schizophr Res; 2009 Jun; 111(1-3):94-102. PubMed ID: 19349150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder.
    Power L; Polari AR; Yung AR; McGorry PD; Nelson B
    Early Interv Psychiatry; 2016 Jun; 10(3):258-62. PubMed ID: 25772939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Movement disorders as a prodromal sign in individuals at high risk of psychosis].
    van Harten PN; Bakker PR; van Os J
    Tijdschr Psychiatr; 2015; 57(2):77-82. PubMed ID: 25669942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Personality features in ultra-high risk for psychosis: a comparative study with schizophrenia and control subjects using the Temperament and Character Inventory-Revised (TCI-R).
    Fresán A; León-Ortiz P; Robles-García R; Azcárraga M; Guizar D; Reyes-Madrigal F; Tovilla-Zárate CA; de la Fuente-Sandoval C
    J Psychiatr Res; 2015 Feb; 61():168-73. PubMed ID: 25554622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effect.
    Hartmann JA; Yuen HP; McGorry PD; Yung AR; Lin A; Wood SJ; Lavoie S; Nelson B
    Schizophr Res; 2016 Jan; 170(1):130-6. PubMed ID: 26673973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
    Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
    Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.
    Ising HK; Ruhrmann S; Burger NA; Rietdijk J; Dragt S; Klaassen RM; van den Berg DP; Nieman DH; Boonstra N; Linszen DH; Wunderink L; Smit F; Veling W; van der Gaag M
    Psychol Med; 2016 Jul; 46(9):1839-51. PubMed ID: 26979398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
    Rekhi G; Rapisarda A; Lee J
    Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Nord J Psychiatry; 2021 Feb; 75(2):97-108. PubMed ID: 32762506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Social dysfunction of young persons with an ultra high risk of developing first-episode psychosis].
    Velthorst E; de Haan L
    Tijdschr Psychiatr; 2014; 56(1):40-9. PubMed ID: 24446226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.
    Ratheesh A; Cotton SM; Davey CG; Lin A; Wood S; Yuen HP; Bechdolf A; McGorry PD; Yung A; Berk M; Nelson B
    Schizophr Res; 2018 Feb; 192():345-350. PubMed ID: 28768599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra-high-risk service.
    Wiltink S; Velthorst E; Nelson B; McGorry PM; Yung AR
    Early Interv Psychiatry; 2015 Jun; 9(3):200-6. PubMed ID: 24224963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
    Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
    Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An attachment perspective on the risk for psychosis: Clinical correlates and the predictive value of attachment patterns and mentalization.
    Boldrini T; Pontillo M; Tanzilli A; Giovanardi G; Di Cicilia G; Salcuni S; Vicari S; Lingiardi V
    Schizophr Res; 2020 Aug; 222():209-217. PubMed ID: 32513546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.